Poland

 

Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.
March 17, 2023

TFP up for sale

HBI hears UK-based pan-European fertility group TFP is up for sale, and speaks to two well-placed sources to find out more.
February 10, 2023

Penta buys one for the future in Poland

Czech-Slovak investment group Penta has acquired Polish hospital group Grupa Nowy Szpital (GNS). With this, Penta is making further inroads into the tricky Polish market. HBI asks, given the state of the Polish market, is now really the right time to buy?
December 1, 2022

MidEuropa buys Optegra

UK, Czechia and Poland-based ophthalmology company Optegra has found a buyer - PE firm MidEuropa has reached a definitive agreement to acquire a majority stake while management and current owners H2 will retain minority stakes.
November 29, 2022

Orpea pledges to pay in full as restructuring rumours continue

French elderly care giant Orpea continues to hit the headlines for all the wrong reasons. Over the last week, dozens of facilities were raided by the French authorities, talk continues to be rife about restructuring and potential exits, and contrary to previous assertions HBI understands the group now intends to pay back the full €56m owed to the state.
November 25, 2022

Scanmed buys Ars Medical

Polish multi-specialty healthcare company Scanmed has bought Polish oncology firm Ars Medical.
November 25, 2022

Orpea to pay France €25.7m

French multinational care group Orpea has agreed to pay back €25.7m of the €55.8m which the French government says it is owed. The company has also decided to sell €2bn of property.  Its shares continue to bounce around €20-25, down from over €100 pre-scandal.
September 2, 2022

Affidea deal – underbidders and EBITDA

HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.
April 28, 2022

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
April 19, 2022
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us